CatalystPit

CRBPCorbus Pharmaceuticals Holdings, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $6.82 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$131.91M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-15 · Ben Yong (Director) · SELL
  • 2026-08-17 · Nicacio Leonardo Viana (Chief Medical Officer) · OTHER
  • 2026-08-12 · Saxena Nishant C (Chief Business Officer) · BUY
  • 2026-08-10 · Cohen Yuval (Chief Executive Officer) · SELL
  • 2026-08-10 · Moran Sean F. (Chief Financial Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders119
Shares held15,905,847
Value$176.87M
Percent of shares outstanding82.24%
As of quarter end2026-06-30
RECENT NEWS
  • Corbus Pharmaceuticals releases Phase 1b results for CRB-913 obesity treatment
  • Corbus Pharmaceuticals reports Phase 1b topline results for CRB-913 in obesity
  • Corbus Pharmaceuticals reports positive CRB-913 obesity trial data
  • CRBP: Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Corbus Pharmaceuticals Holdings, Inc. (CRBP) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit